AI Summary & Key Takeaways
AI InsightOverall mortality was 65.9%.CONCLUSION: Domiciliary NIMV can be of benefit to very elderly patients, and age is not an obstacle.
📌 3 Key Takeaways
Özet
OBJECTIVES: The aim of this study was to investigate the use of domiciliary non-invasive mechanical ventilation (NIMV) in very elderlypatients (age 80 and over).MATERIALS AND METHODS: This retrospective study included a total of 44 patients aged 80 years or older, who were admitted to theHealth Sciences University, Süreyyapaşa Chest Diseases and Thoracic Surgery Training and Research Hospital, Pulmonary Intensive CareOutpatient Clinic between 2012 and 2018 and applied NIMV for chronic respiratory failure. The patients were divided into two groups:survivors (n=15) and non-survivors (n=29). Data were obtained from the retrospectively formed hospital database. The characteristics ofpatients, comorbidities, NIMV compliance, pulmonary function tests, and blood gas analyses were compared between the survivors andnon-survivors.RESULTS: From the retrospective analysis of 44 cases, the non-survivors were found to have a significantly shorter duration of domiciliaryNIMV (737 days vs. 890 days, p=0.027) and lower hemoglobin concentration (11.1 g/L vs. 12.9 g/L, p=0.004). The number of comorbidconditions, pulmonary function test, and blood gas analyses results did not differ significantly between the groups. Compliance wasmoderate in this elderly population, at 4.9±1.9 h/day (range: 0.8-9.1 h/day). NIMV was well-tolerated in 36 of the 44 elderly patients(81.8%). Overall mortality was 65.9%.CONCLUSION: Domiciliary NIMV can be of benefit to very elderly patients, and age is not an obstacle. Therefore, this population shouldnot be excluded from this treatment solely on the basis of age.